Clinical Trials Logo

Depression clinical trials

View clinical trials related to Depression.

Filter by:

NCT ID: NCT04397835 Completed - Depression Clinical Trials

Psychological Impact of COVID-19 Quarantine and Worsening of Cardiovascular Risk in the French General Population

PSYCOV-CV
Start date: April 17, 2020
Phase:
Study type: Observational

In response to the COVID-19 outbreak, the French government put in place home quarantine of the general population in order to limit the transmission of the virus. It is obvious that quarantine at home have a psychological impact which could worsened cardiovascular risk. Our aim is to assess risk factors for severe stress, anxiety or depression, during and after quarantine, as well as risk factors (including stress, anxiety or depression), in the worsening of cardiovascular risk.

NCT ID: NCT04396509 Completed - Clinical trials for Postnatal Depression

Effects of Type of Delivery Mode and Gestational Age on Maternal Bonding

Start date: June 1, 2018
Phase:
Study type: Observational

To evaluate the effects of gestational age and other factors on maternal attachment relationship. There are different results in studies examining the effects of birth type on postpartum depression and mother-infant interaction. The aim of this study was to evaluate factors which affected mother-infant bond (MIB) using maternal attachment inventory (MAI).

NCT ID: NCT04395183 Completed - Clinical trials for Major Depressive Disorder

5-HTP and Creatine for Depression

Start date: March 1, 2021
Phase: Phase 2
Study type: Interventional

This is a three-armed clinical trial examining the effect of 5-hydroxytryptophan and creatine monohydrate as augmenting agents for the treatment of depression. Subjects will be randomized between 5-HTP + placebo, creatine + placebo, and 5-HTP + creatine, for 8 weeks. The ability of the interventions to affect biomarkers associated with depression will be assessed using brain phosophorus magnetic resonance spectroscopy, functional connectivity imaging, and plasma serotonin levels.

NCT ID: NCT04394078 Completed - Depression Clinical Trials

Impact of COVID-19 Pandemic on Depression and Quality of Life

Start date: May 6, 2020
Phase:
Study type: Observational

It is aimed to investigate the depression and quality of life of Turkish society caused by Covid-19 pandemic and reveal the relationship between them

NCT ID: NCT04393818 Completed - Depression Clinical Trials

Mobile Phone Based Intervention to Protect Mental Health in Healthcare Workers at Frontline Against COVID19

PsyCovid_App
Start date: May 5, 2020
Phase: Phase 3
Study type: Interventional

This study aims at evaluating the effectiveness of a mobile phone based intervention to prevent and manage mental health problems in healthcare workers at the frontline against COVID-19 in Spain. The intervention will consist in psychoeducation, delivered via a mobile App. Participants will be followed up during two weeks. The primary outcome will be symptomatology of depression, anxiety or stress.

NCT ID: NCT04388800 Completed - Depression Clinical Trials

Online Cognitive Behavioral Intervention Program for Hong Kong People With Depression

CANDO
Start date: January 1, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to develop a culturally and linguistically appropriate online cognitive behavioral intervention program-- with therapist guidance -- for Hong Kong Chinese adults suffering from major depressive disorder with mild to moderate depressive symptoms, and examine the effectiveness of this program in reducing their depressive symptoms and improving their mental health. The 3- and 6-month maintenance effect after 3 months and 6 months will also be tested.

NCT ID: NCT04388748 Completed - Major Depression Clinical Trials

Stress Management and Resiliency Training for Depression vs Treatment as Usual in the Treatment of Major Depression

Start date: December 18, 2020
Phase: N/A
Study type: Interventional

Researchers are trying to find out if a Stress Management and Resiliency Training (SMART-D) therapy will help with major depression treatment.

NCT ID: NCT04385394 Completed - Depression Clinical Trials

Bright Light Therapy as Augmentation of Depressive Symptoms on Acute Psychiatric Floor

BLT
Start date: January 30, 2020
Phase:
Study type: Observational

The purpose of this study is to explore if Bright Light Therapy (BLT) as augmentation of depression treatment on an acute psychiatric floor is feasible, helps alleviate depressive symptoms, improve functioning, and decrease length of stay on the psychiatric floor.

NCT ID: NCT04385238 Completed - Depression Clinical Trials

Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic

Start date: May 15, 2020
Phase:
Study type: Observational

The purpose of this study is to assess the health and wellbeing of pregnant and recently pregnant women during the COVID-19 pandemic using an online survey.

NCT ID: NCT04385121 Completed - Depression Clinical Trials

Psychological Impact of the Hospitalization of a Family Member in Intensive Care for Covid-19 Infection

Familles-COVID
Start date: April 16, 2020
Phase:
Study type: Observational

The hospitalization of a patient in intensive care is a traumatic experience for his family members. With the current COVID-19 epidemic, in view of the high risk of contamination, drastic measures to limit the transmission are necessary, with the creation of spaces dedicated to the care of Covid+ patients, and family are not allowed to visit. At the Strasbourg University Hospital, visits were prohibited from the start of the epidemic. Information concerning the patient's state of health is therefore delivered to families by telephone, on call by the healthcare team only, every day before 6 p.m. or in the event of a serious event at any time. The primary purpose of this project is to assess the psychological impact of the hospitalization of a loved one in intensive care for Covid-19 infection at 3 months post-hospitalization, in a context of pandemic with ban on visits.